标题
Glucose-deprivation increases thyroid cancer cells sensitivity to metformin
作者
关键词
-
出版物
ENDOCRINE-RELATED CANCER
Volume 22, Issue 6, Pages 919-932
出版商
Bioscientifica
发表日期
2015-09-12
DOI
10.1530/erc-15-0402
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Multimodal Holographic Microscopy: Distinction between Apoptosis and Oncosis
- (2015) Jan Balvan et al. PLoS One
- The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: Implications for cancer therapy and prevention
- (2014) Beshay N.M. Zordoky et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Metformin impairs growth of endometrial cancer cells via cell cycle arrest and concomitant autophagy and apoptosis
- (2014) Akimasa Takahashi et al. Cancer Cell International
- Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders
- (2014) S. Gandini et al. Cancer Prevention Research
- Molecular Pathways: Preclinical Models and Clinical Trials with Metformin in Breast Cancer
- (2014) A. M. Thompson CLINICAL CANCER RESEARCH
- Depletion of the Central Metabolite NAD Leads to Oncosis-mediated Cell Death
- (2014) Christopher Del Nagro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Therapeutic potential of metformin in papillary thyroid cancer in vitro and in vivo
- (2014) Sun Wook Cho et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
- (2014) Kıvanç Birsoy et al. NATURE
- Metformin—mode of action and clinical implications for diabetes and cancer
- (2014) Ida Pernicova et al. Nature Reviews Endocrinology
- Mechanisms by Which Low Glucose Enhances the Cytotoxicity of Metformin to Cancer Cells Both In Vitro and In Vivo
- (2014) Yongxian Zhuang et al. PLoS One
- Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK
- (2014) X. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
- (2014) William W Wheaton et al. eLife
- Glucose promotes breast cancer aggression and reduces metformin efficacy
- (2013) Reema Wahdan-Alaswad et al. CELL CYCLE
- Aberrant Overexpression of Pyruvate Kinase M2 Is Associated With Aggressive Tumor Features and theBRAFMutation in Papillary Thyroid Cancer
- (2013) Chen Feng et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment With Metformin Is Associated With Higher Remission Rate in Diabetic Patients With Thyroid Cancer
- (2013) Joanna Klubo-Gwiezdzinska et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metformin Use and All-Cause and Prostate Cancer–Specific Mortality Among Men With Diabetes
- (2013) David Margel et al. JOURNAL OF CLINICAL ONCOLOGY
- Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells
- (2013) S Scotland et al. LEUKEMIA
- Metabolic roles of AMPK and metformin in cancer cells
- (2013) Yeon Kyung Choi et al. MOLECULES AND CELLS
- Metformin Is Associated With Survival Benefit in Cancer Patients With Concurrent Type 2 Diabetes: A Systematic Review and Meta-Analysis
- (2013) M. Yin et al. ONCOLOGIST
- Mitochondria-Targeted Drugs Synergize with 2-Deoxyglucose to Trigger Breast Cancer Cell Death
- (2012) G. Cheng et al. CANCER RESEARCH
- Metformin is synthetically lethal with glucose withdrawal in cancer cells
- (2012) Javier A. Menendez et al. CELL CYCLE
- Oncosis: An important non-apoptotic mode of cell death
- (2012) Priya Weerasinghe et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- A model for cardiomyocyte cell death: Insights into mechanisms of oncosis
- (2012) Priya Weerasinghe et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Metformin Inhibits Growth of Thyroid Carcinoma Cells, Suppresses Self-Renewal of Derived Cancer Stem Cells, and Potentiates the Effect of Chemotherapeutic Agents
- (2012) Guofang Chen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Untuning the tumor metabolic machine: Targeting cancer metabolism: a bedside lesson
- (2012) Kıvanç Birsoy et al. NATURE MEDICINE
- Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
- (2012) Michael N. Pollak Cancer Discovery
- Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
- (2011) I. Ben Sahra et al. CANCER RESEARCH
- Dual Inhibition of Tumor Energy Pathway by 2-Deoxyglucose and Metformin Is Effective against a Broad Spectrum of Preclinical Cancer Models
- (2011) J.-H. Cheong et al. MOLECULAR CANCER THERAPEUTICS
- The combination of metformin and 2 deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells
- (2010) Issam Ben Sahra et al. Autophagy
- Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner
- (2010) Adem Kalender et al. Cell Metabolism
- Induction of Autophagy and Inhibition of Melanoma Growth In Vitro and In Vivo by Hyperactivation of Oncogenic BRAF
- (2010) Nityanand Maddodi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: Present status and future prospects
- (2009) BS Dwarakanath et al. Journal of Cancer Research and Therapeutics
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification
- (2008) Rebecca E. Schweppe et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
- (2008) Heather R. Christofk et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More